DuoTox is the first product to combine activated charcoal and diosmectite, providing a wider spectrum of absorbency against various toxic substances.
Accidental poisoning poses a significant threat to pets, with vets in the UK reporting over 30001 cases a week and making an average 60 calls a day to the VPIS for assistance2
In 2020, 7.1 million pets fell ill after eating something poisonous1 and the VPIS reported a 40% increase in poisoning enquiries in 20212.
The most commonly used product for accidental ingestion is activated charcoal, but it only has affinity for certain substances.
Diosmectite also only binds to select substances, but is not as widely used.
Up until now, the two have not been used together in one product, leaving situations where the chosen binder has no effect.
NVS says that in cases of potential ingestion, identifying the exact substance consumed, and relying on vets to know which binder to use for each substance, is a barrier to successful toxin binding.
Malcolm Dickinson, Category Manager for Select from NVS, said: “Activated charcoal has affinity for substances that are, for example acidic, non-ionised or poorly water soluble, leaving a gap for substances that are alkaline, cationic, hydrophilic etc.
"This is where the absorbency profile of diosmectite comes in to create one product with a much wider spectrum of adsorbency.”
“This will be hugely beneficial to vets in practice: vets can reach for one product, knowing it will be effective.”
DuoTox is available in both paste and liquid forms, designed with palatability in mind.
https://www.nvsweb.co.uk/product-brand/select-healthcare/
References:
At the heart of the campaign is a website - www.beatdogheartdisease.co.uk - where dog owners can learn more about mitral valve disease and dilated cardiomyopathy, find out which breeds are most at risk and read more about the diagnosis and management of canine heart disease.
Boehringer has also created a Facebook page - www.facebook.com/beatcanineheartdisease - offering regular updates on heart health and a platform for owners to share their stories. Owners can also use the ‘Love Your Dog’s Heart’ Facebook profile frame to help spread awareness of the disease.
The aim of the campaign is to get pet owners thinking about mitral valve disease and having it treated whilst it is still in the asymptomatic phase, in order to slow the disease progression and delay the onset of heart failure1.
Vetmedin practices can access additional ‘Love Your Dog’s Heart’ campaign materials via the Boehringer Ingelheim Resource Hub at boehringer-ingelheim-resourcehub.co.uk.
Reference
An amendment to the EU's draft budget for a €2 million pilot research project into homeopathy and phytotherapy for farm animals has been approved today by the European Parliament's Agriculture Committee.
BVA President Harvey Locke, said: "Millions of Euros have already been spent on trying to prove the scientific efficacy of homeopathic medicines. To date we have not seen any data to prove they can be effective in the treatment of bacterial infections.
"Whilst it is unlikely that €2 million will be able to determine whether or not there is a basis for claiming homeopathic products can work, we welcome European investment in veterinary research and hope that the results of the pilot will be useful."
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
The first is to confirm officially that Suprelorin, it's non-surgical alternative for neutering male dogs, may be implanted by RVNs under the direction of a veterinary surgeon under Schedule 3 of the Veterinary Surgeons Act.
The company is also hosting two free webinars for nurses to learn more about neutering: The Science of Canine Castration and Practical Tips for Clinics, presented by Dr Michelle Kutzler and Nicola Lakeman on Thursday 9th December 2021, and Behaviour in Post-Pandemic Puppies and Practical Tips for Clinics, presented by Stephanie Hedges and Nicola Lakeman on Thursday 16th December 2021.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "A huge surge in dog ownership in the last two years, combined with the additional pressures of Covid-19, has massively increased pressures on veterinary teams.
"At the same time we know that pet owner attitudes to surgical neutering is changing with 1 in 3 pet owners saying that they would look at alternative methods to surgical castration1.
"Suprelorin offers practices the opportunity to utilise the skills of their RVNs to provide a choice to clients when it comes to neutering and help to ease pressures on surgical waiting lists".
Ceva Animal Health has published Causes of scour in growing pigs: an overview, a technical review on pig scour.
The company says its aim is to provides vets with an easy-reference guide to the main causes and clinical signs of this common and potentially fatal condition.
At best, scour in growing pigs can cause significant weight loss and damage to the intestinal mucosa. At worst it will result in high mortality. Causes of scour in growing pigs: an overview summarises the causative agents of scour throughout the stages of growth, from sucking piglets through to finisher pigs.
Ceva adds that although it is difficult to be too prescriptive about assigning clinical signs to specific diseases because of variable immunity and the occurrence of mixed infections, the review provides useful guidelines to aid accurate diagnosis. Preventative management strategies are also discussed where applicable.
For further product information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
The company says the like-for-like sales increase was at the upper end of its target of between 4% and 8%, and that it continues to see resilience in the veterinary sector, with membership of its Healthy Pet Club preventative healthcare scheme increasing in the year by 19,000 members (an increase of 4.0%) to 489,000.
CVS says its Board decided to enter the Australian marketplace because of its low levels of corporate consolidation, favourable market dynamics and strong similarities with the UK, including highly trained veterinary surgeons, shared language and culture, and the group's experience with UK vets working between Australia and the UK.
Earlier this month, the group signed agreements for the conditional acquisitions of four independent small animal first opinion veterinary practices in Australia: two in Brisbane, one in Queensland and one in Sydney, for an initial consideration of £16.8M.
Two of the acquisitions have now been completed, and the other two are expected to be completed shortly.
The company says it now plans to acquire more Australian practices in major urban conurbations, including Sydney, Melbourne, Brisbane, Perth, Canberra, Newcastle and Adelaide.
Ben Jacklin, Deputy CEO said: "Having worked as a vet in Australia earlier in my career, I know well their high standards of clinical care, and the dedication of highly talented veterinary professionals that work there.
"As a company dedicated to giving the best possible care to animals, I see a fantastic opportunity for us to enter this growing market, with low levels of corporate consolidation, and execute our vision of being the veterinary company people most want to work for.
"I have spent time in Australia over the last 12 months, including meeting some fantastic veterinary practices, and it is clear we have a significant opportunity.
"With the four outstanding practices that are joining us, and a strong pipeline of further acquisition opportunities, I am excited to build a significant CVS business in Australia with the same culture and values that have brought us success in the UK."
New research released today by Petplan has revealed that at a time when marriage is in decline and the average child bearing age is increasing, a new breed of pet owner has emerged: women between the ages of 25 and 34 who bought their pet as a substitute for a child.
More than 10,000 pet owners were surveyed for the research and the results apparently reveal 'pet parenting' as a growing trend. According to the survey, women not only look to their furry friend for companionship but also treat them like they would a child, with nearly 70% buying them birthday and Christmas presents, 28% adapting their homes for their pet and 20% changing their holiday destinations to allow their pet to come along too.
Just like working parents, owners worry about leaving their pet alone when they're working. So much so that they make a concerted effort to make sure their pet is not left alone for more than five hours a day - employing dog walkers and cat sitters to stem their concern (approaching 1 in 7). When an 8 hour working day is the national norm and the average parent only spends 49 minutes a day with their children, this demonstrates considerable pet commitment.
Dr Deborah Wells, expert in the study of the psychology of the pet-human relationship said: "Dogs and cats can offer their owners many of the benefits frequently provided by children, including companionship, entertainment and happiness. For some owners, notably women, pets can provide a useful training ground in 'motherhood', in some cases helping to shape important decisions on whether or not children are to be a part of their future. For others, pets can serve as a child 'substitute', offering people who choose not to have, or cannot conceive, children, an outlet for emotional attachment and nurturing behaviour."
Petplan's marketing manager Alison Andrew said: "This pet parenting theme is one of the most significant trends to come out of Petplan's biggest body of research to date - the Petplan Pet Census - which looks into the realities of pet ownership. We see the amazing lengths that owners go to for their pets every day and the level of worry that goes with it. Our job is to give owners peace of mind through our insurance plans, so they can be confident their beloved companion will always receive the best care and treatment without having to worry about the financial costs. We want to use this research to truly understand modern pet ownership in the UK so that we can better provide help and guidance for our nation of pet lovers!"
If you'd like to take part in the Petplan Pet Census, documenting the picture of pet ownership in Britain, visit www.petplan.co.uk
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
The resource includes content from Companion, BSAVA Congress, and the BSAVA Manual of Wildlife Casualties.
Topics range from hand-rearing to anaesthesia to relevant legal questions and cover both hedgehogs and general wildlife casualties.
Liz Mullineaux, RCVS Recognised Specialist in Wildlife Medicine (Mammalian), Senior Vice President of the British Veterinary Zoological Society, and editor of the BSAVA Manual of Wildlife Casualties, said: "Hedgehogs are the most common mammalian wildlife casualty seen by veterinary surgeons.
"Those caring for these animals have very variable knowledge and look to vets for appropriate help, advice, and clinical care.
"It’s therefore really important that vets and vet nurses in practice have some good information about hedgehogs to hand.
"As well as knowing about clinical conditions, a broader understanding of wildlife rehabilitation is essential.
The collection, which costs £20.00 for BSAVA members or £45.00 for non-members, can be accessed via the BSAVA Library: https://www.bsavalibrary.com/content/hedgehogs.
Millpledge has launched Dermafuse Tissue Adhesive, an n-butyl cyanoacrylate medical adhesive used to bond tissue together following veterinary procedures.
Dermafuse contains a blue dye to help users see where product has been applied.
On contact with body tissue, Dermafuse changes from liquid to solid state by polymerizing within seconds to seal the wound.
Millpledge says the adhesive stops minor bleeding and binds wound edges, which may eliminate the need for sutures or bandages. In some instances it also acts as a barrier to keep foreign matter from entering the wound. The tissue adhesive is sloughed as healing occurs.
Each 3g bottle contains approximately 175 drops. Four sterile applicator tips are provided with each pack.
The British Veterinary Association has responded to the announcement of a recruitment drive by the newly-formed British Veterinary Union (BVU) and Unite.
Harvey Locke, President of the BVA, said: "Those working in veterinary practice have always been able to join Unite or any other trade union, and it is unclear whether vets are actually being offered anything new in this recruitment campaign.
"The BVA provides the majority of services traditionally offered by a union and we are constantly working to improve our services to support the veterinary team. In the last two years we have developed mediation and legal representation services to help members through difficult issues in the workplace. The BVA's 24/7 legal helpline remains one of our most valued services with up to 600 calls year on employment and personal issues. We also produce and update a wide range of advice and guidance on all aspects of veterinary employment.
"All of our services continue to be developed using the expertise and experiences of our members.
"In addition to these support services the BVA package incorporates much more. The BVA is a key stakeholder of the RCVS, Defra, Welsh, Scottish and Northern Ireland administrations, the VMD and other bodies, representing members on issues as diverse as pet travel, bovine TB and medicines regulations. This is not a role Unite could play for our profession."
This third biennial offering from GB’s Cattle Health and Welfare Group also contains a summary of progress on endemic disease control with advances in eradicating Bovine Viral Diarrhoea (BVD) in each country highlighted.
The Chief Veterinary Officers of UK, Scotland and Wales have welcomed the publication of the report saying that as the possible impacts of the referendum on leaving the EU are considered, the importance of a GB focus on disease control is as important as ever.
In their joint forward, Nigel Gibbens, Sheila Voas and Christianne Glossop said: "The healthier our animals, the more attractive our products. The better our animal welfare, the greater the confidence of consumers in our production systems.
"With the UK Government placing AMR at the top of its risk register alongside terrorism and pandemic ’flu, it is heartening to see that CHAWG, in common with other livestock sectors, has grasped the nettle in looking first at how the cattle sector can better capture data on use of antimicrobials."
They go on to say that addressing AMR helps address other imperatives as an emphasis on sound animal husbandry and healthy animals kept to high welfare standards will help minimise routine reliance on antimicrobials: "Success in controlling endemic disease is one area of considerable importance, and here we can highlight CHAWG’s pivotal role in the development and promotion of national disease control programmes. These include the launch of the BVDFree scheme in England earlier this year, ongoing progress with BVD eradication in Scotland, the development of a Wales BVD scheme, and the Action Johne’s initiative."
In the report’s conclusion, RSPCA’s head of farm animals Marc Cooper points out that it is clear many positive initiatives are being pursued within the industry. He said: "Notable amongst these are those associated with dairy cow genetics, eliminating BVD, the national dairy cow welfare strategy and the development of a data hub for the collation of information relating to antimicrobial use.
"Indeed, some of these are starting to realise improvements in key areas, for example, dairy cow longevity is beginning to increase, and cow fertility figures and somatic cell counts appear to be moving in the right direction.
"However, there are still ongoing concerns relating to some important health and welfare issues. For example, despite the evidence suggesting the annual prevalence levels of cattle lameness are beginning to fall, there still appears to be no centralised database for recording it."
Chairman of CHAWG Tim Brigstocke says the contributed comments are encouraging and provide positive direction for future CHAWG activities. He also reassures that while this report sees a number of advances in highly topical areas, ‘core’ activities are not being ignored. He said: "Effective farm health planning remains the bedrock of good practice. And while we tend to focus on areas which need improvement, it’s worth mentioning that a delegation from the Food & Veterinary Office (FVO) of the European Commission recently visited and were impressed by the coordinated approach taken in this country."
The report can be downloaded from www.chawg.org.uk.
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
Dave Dickson MRCVS (pictured right) said: "The ECG series is full of case examples and practical advice, delivered by the friendly cardiologists at HeartVets.
"The course should give you confidence to record and interpret ECGs in practice, knowing how to put the ECG information into context with each case and improving how you manage cardiac cases in practice."
ECGs for Vets and Nurses, an online course offering an introduction to ECGs.
The course, which costs £95 for three month's access, has over seven-and-a-half hours of content, divided up into 20-45 minute webinars, so you can watch at your own pace.
For more information, visit: https://heartvets.co.uk/learning-zone/
The toolkit includes a 15-minute CPD webinar: ‘How to best use ProZinc to successfully manage diabetes in cats and dogs’, hosted by Dr Jamie Adams BVSc PhD MRCVS, Senior Brand Technical Advisor at Boehringer Ingelheim.
Vets who watch the webinar can enter a competition for a coffee machine for their veterinary practice by answering three questions at the end.
The toolkit also has a diabetes management reference guide covering how to make a confident diagnosis and start treatment with ProZinc, how best to monitor and reassess the patient and how to adjust the dose for optimal control.
There are also glucose curve charts, pet owner guides, home care journals and a link to the ProZinc pet owner website, www.prozinc.co.uk, which contains information to help owners feel confident in managing their pet’s diabetes.
The webinar and toolkit are available from: www.boehringer-academy.co.uk.
The survey of 1,019 dog owners was conducted by petbuzz in December 2022.
Veterinary cardiology specialist, Dr Rachel James, said: “The CKCS has long been a very popular breed of dog in high demand, due to their loving and placid nature making them perfect family pet.
"We know that sadly at least 50% of CKCS have evidence of MVD disease by the time they are five, with 98% of dogs affected in their lifetimes.
"However, we can help our clients when selecting this breed to choose a puppy that is less likely to develop MVD at an early age, by utilising the heart testing scheme (Doppler heart testing).
"Prospective owners should be asking to see test results for the parents, grandparents, and even better great grandparents too, on both maternal and paternal sides.
"In addition breeders need more support and education to encourage the use of the heart testing scheme and how this can enable them to choose the best dogs to breed from.
"Furthermore we should be encouraging breeders to breed from dogs only when they are at least 3 years of age.”
Vita Animal Health commissioned the survey to raise awareness of the condition and to remind owners to use their vet’s expertise.
Vita’s veterinary nurse, Tara Evans, said: “The CKCS is a very popular breed of dog, perhaps set to be more so now King Charles III is reigning monarch.
"This survey has shown that awareness of mitral valve disease – which is very common in this breed – is not as good as it could be.
"We want to support vets in raising awareness and have useful resources such as our heart disease infographic (www.vitaanimalhealth.com/common-signs-of-heart-disease) that we welcome all vets in using.”
The Action Plan presents what the College is doing to tackle the issue and explains how collaboration, culture change, career development and leadership, among other things, could help with workforce shortages by improving retention of current members of the professions, encouraging more people to join, and making it easier for those who have left the professions to return.
The report lists seven main areas to be addressed:
The full list of actions, with context about what has fed into ambitions, can be found in the Action Plan which is downloadable at www.rcvs.org.uk/publications.
Dr Sue Paterson FRCVS, Junior Vice-President and Chair of the RCVS Advancement of the Professions Committee, said: “This is a very complex, broad and multi-faceted area of concern so the Action Plan has been a long time in the making to ensure that we adequately capture what needs doing and how, in order to enable us to work collaboratively with all veterinary organisations going forward.
"This is not a finished list, but gives all within the veterinary sector the ability to look at the key areas of work that need to be done and prioritise the ones that most suit their organisational needs."
The partnership includes a minimum donation of £10,000 which the company hopes to bolster with additional volunteering and fundraising support.
Gerard Ensink, Head of Animal Health UK and Ireland at Boehringer Ingelheim said: “We are truly delighted to be supporting StreetVet.
“There is already so much passion for the charity within our company.
"Even before we announced this charity partnership, several of our colleagues have been volunteers with StreetVet in a personal capacity.
"We look forward to supporting StreetVet and believe that together we can make a real difference to individuals and their pets who are experiencing homelessness.”
https://www.streetvet.co.uk
Axiom Laboratories has launched MiPetAllergy, a pet allergy test which the company says is not affected by medication and which requires no withdrawal period prior to testing.
Axiom developed the MiPetAllergy in partnership with ALK, which makes Artuvetrin. With its food elimination diet selector tool, developed in association with Royal Canin, it tests against as many as 80 environmental allergens and foods.
Dan Sherry, General Manager at Axiom, said: "Allergies are increasing among companion animals and identifying accurately which allergen is causing the problem in a particular pet can be one of the toughest challenges veterinary staff face in practice.
"MiPetAllergy represents two and half years of research so we are delighted to announce its arrival. Axiom is confident that there will be complete concordance between the screen and panel results that they are offering a money back guarantee if they are discordant. We hope it will help practices dealing with allergy patients to identify and treat for the specific allergens causing their symptoms."
Martyn Carpenter, Director of Axiom, added: "The introduction of the MiPetAllergy testing is timely as it coincides with the change in Axiom’s supplier of immunotherapy. During November and December 2014 the Veterinary Medicines Directorate (VMD) started rejecting applications for STC’s and advising that European Licensed immunotherapy products should now be used in the UK as part of the Cascade. Both our new allergy test and new vaccines are manufactured by the same company."
Fees will now be £340 for a UK-practising member, £170 for members practising outside the UK, £56 for non-practising vets under the age of 70, and free for non-practising vets over 70.
Restoration fees, charged in addition to retention fees, increase to £85 following voluntary removal, and £340 following removal for non-payment.
Lizzie Lockett, RCVS CEO, said: "This year we asked Council to agree a fee increase to help us prepare for unknowns such as Brexit, as well as fortify our proactive work to help support the professions.
"Over the past few years we have put increased resources into projects such as: Mind Matters, our mental health initiative; Vet Futures, our joint project with the British Veterinary Association; Vivet, our innovation hub; and our recently launched Leadership Programme. Unfortunately there has also been a rise in Disciplinary Committee hearings and we are having to allocate further funds to making our building fit for purpose, and so a small increase has been necessary.
"This still places us at the lower end of fees for regulatory bodies while providing a secure financial foundation."
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
60 vets took part in the survey. 80% believed they had seen an increase in behavioural problems since lockdown. Over 60% reported an increase in the incidence of obesity and diarrhoea. Nearly 50% had seen an increase in urinary tract disorders and haemorrhagic gastroenteritis.
When asked which conditions had been harder to manage clinically since the start of the pandemic, the top seven conditions were:
Medicine specialist, Dr Stefanie Mitze (pictured right) said: “We conducted the survey to help us understand changes in disease incidence and the clinical challenges faced by our colleagues in first opinion practice over the last year.
"The fact that the incidence of disorders which can have a stress-related component, including behavioural problems, diarrhoea and urinary tract disease, were reported to have increased by a high proportion of respondents indicates that many pets may be experiencing heightened stress during the pandemic.”
Stefanie is now creating a series of free bitesize CPD videos to help manage these more challenging cases. She said: “We recognise the past year has been challenging, especially with complex staffing issues, reduced vet visits and restricted face-to-face communication with clients. For complex, chronic medical conditions, especially those which require frequent follow up, we wanted to support colleagues in providing the best care possible in the current circumstances. We hope these CPD sessions will provide practical tips to help deliver just that.
The CPD sessions are available at: https://www.hamiltonspecialists.vet
Virbac Animal Health has launched a broad spectrum wormer for dogs called Endogard (praziquantel, pyrantel and febantel).
Virbac says Endogard offers treatment against most types of intestinal worms found commonly in dogs. It is presented in two tablet sizes for easy dosage.
Victoria Hudson, Product Manager for Endo and Ectoparasiticides, said: "While we're known for developing innovative products which help practices generate additional revenue streams, we can also support them by offering cost-effective and proven products for routine use.
Endogard is a perfect example. The efficacy of its active ingredients is well-established; it's simple for owners to administer and it's also affordable which will bring them back to the practice. It's an excellent addition to Virbac's strong range of parasite control treatments."
For further information, contact your Territory Manager or call Virbac on 01359 243243.
From the start of 2016, the RCVS will no longer allow veterinary surgeons or veterinary nurses to enter undocumented continuing professional development (CPD) on their records.
Under the RCVS Codes of Professional Conduct, veterinary surgeons are required to record a minimum of 105 hours of CPD over a three-year period, while veterinary nurses are expected to carry out 45 hours of CPD over the same period.
Historically, vets and nurses have been able to record 10 and 5 hours as undocumented private study per annum respectively. The RCVS Education Committee decided to discontinue the allowance for vets in May and the Veterinary Nursing Committee followed suit in June.
Julie Dugmore, RCVS Head of Veterinary Nursing, said: “As with the veterinary surgeons, this decision was made because it was felt that all CPD, including private study, should be properly documented on the CPD records of veterinary nurses.
“This change, however, is not intended to discourage private study which we recognise extends across a range of different types of learning, including reading, and can be very valuable for personal development, but merely that it should be properly documented.”
The College says it hopes the changes will also clear up uncertainty around the respective allowances for veterinary surgeons and veterinary nurses, as some were under the impression that private study, even if it was documented, could only be classed within that category.
The Education Department is also in the process of reviewing the information available to veterinary surgeons and veterinary nurses regarding what counts as CPD, in order to clear up uncertainty and provide more specific examples for each learning category.
Information about CPD for veterinary surgeons can be found at www.rcvs.org.uk/cpd, while for veterinary nurses the information is available at www.rcvs.org.uk/vncpd